The modern concept of mastodynia

Cover Page

Cite item

Full Text

Abstract

Mastodynia is a condition characterized by painful sensations in the breasts. It is diagnosed in middle-aged women in the reproductive 50%, while in the older age group it is significant; y lower - 5%. Pain in the breast may be cyclic and non-cyclic in nature. Cyclical is associated with the hormonal changes of the menstrual cycle, bilateral, more pronounced in the upper outer quadrant of the breast. Non-cyclic is permanent or intermittent in nature, one-way. Their cause is stretching in the Cooper ligaments, smoking, ductal ectasia, mastitis, an inflammatory cancer, pregnancy, thrombosis, trauma, cysts, previous breast surgery and the use of drugs. Diagnosis mastalgia includes patient survey, physical examination, ultrasound scan, and mammography. Treatment consists in the normalization of diet, and symptomatic medication.

About the authors

S. A Levakov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

д-р мед. наук, проф., зав. каф. акушерства и гинекологии ИПО ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

E. I Borovkova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: katyanikitina@mail.ru
д-р мед. наук, проф. каф. акушерства и гинекологии ИПО ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

References

  1. Ader D.N, Shriver C.D. Cyclical mastalgia: prevalence and impact in an outpatient breast clinic sample. J Am Coll Surg 1997; 185: 466.
  2. Seltzer M.H. Breast complaints, biopsies, and cancer correlated with age in 10,000 consecutive new surgical referrals. Breast J 2004; 10: 111.
  3. Scurr J, Hedger W, Morris P, Brown N. The prevalence, severity, and impact of breast pain in the general population. Breast J 2014; 20: 508.
  4. Davies E.L, Gateley C.A, Miers M, Mansel R.E. The long - term course of mastalgia. J R Soc Med 1998; 91: 462.
  5. Ader D.N, Browne M.W. Prevalence and impact of cyclic mastalgia in a United States clinic - based sample. Am J Obstet Gynecol 1997; 177: 126.
  6. Ader D.N, South-Paul J, Adera T, Deuster P.A. Cyclical mastalgia: prevalence and associated health and behavioral factors. J Psychosom Obstet Gynaecol 2001; 22: 71.
  7. Levinson W, Dunn P.M. Nonassociation of caffeine and fibrocystic breast disease. Arch Intern Med 1986; 146: 1773.
  8. Jacobson M.F, Liebman B.F. Caffeine and benign breast disease. JAMA 1986; 255: 1438.
  9. Heyden S, Muhlbaier L.H. Prospective study of "fibrocystic breast disease" and caffeine consumption. Surgery 1984; 96: 479.
  10. Minton J.P, Foecking M.K, Webster D.J, Matthews R.H. Caffeine, cyclicnucleotides, andbreastdisease. Surgery 1979; 86: 105.
  11. Abraham G.E. Nutritional factors in the etiology of the premenstrual tension syndromes. J Reprod Med 1983; 28: 446.
  12. Archer D.R, Fischer L.A, Rich D et al. Estracevs Premarin for treatment of menopausal symptoms: dosage comparison study. Advancesin Therapy 1992; 9: 21.
  13. Bech P, Munk-Jensen N, Obel E.B et al. Combined versus sequential hormonal replacement therapy: a double - blind, placebo - controlled study on quality of life - related outcome measures. Psychother Psychosom 1998; 67: 259.
  14. Greendale G.A, Reboussin B.A, Hogan P et al. Symptom relief and side effects of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin Interventions Trial. Obstet Gynecol 1998; 92: 982.
  15. Peters F, Diemer P, Mecks O, Behnken L.L.J. Severity of mastalgia in relation to milk duct dilatation. Obstet Gynecol 2003; 101: 54.
  16. Smith R.L, Pruthi S, Fitzpatrick L.A. Evaluation and management of breast pain. Mayo Clin Proc 2004; 79: 353.
  17. Morley J.E, Dawson M, Hodgkinson H, Kalk W.J. Galactorrhea and hyperprolactinemia associated with chest wall injury. J Clin Endocrinol Metab 1977; 45: 931.
  18. Love S.M, Gelman R.S, Silen W. Sounding board. Fibrocystic "disease" of the breast - a nondisease? N Engl J Med 1982; 307: 1010.
  19. Devitt J.E. Abandoning fibrocystic disease of the breast: timely end of an era. CMAJ 1986; 134: 217.
  20. Hutter R.V. Goodbye to "fibrocystic disease". N Engl J Med 1985; 312: 179.
  21. Morrow M. The evaluation of common breast problems. Am Fam Physician 2000; 61: 2371.
  22. Leddy R, Irshad A, Zerwas E et al. Role of breast ultrasound and mammography in evaluating patients presenting with focal breast pain in the absence of a palpable lump. Breast J 2013; 19: 582.
  23. Boyd N.F, Mc Guire V, Shannon P et al. Effect of a low - fat high - carbohydrate diet on symptoms of cyclical mastopathy. Lancet 1988; 2: 128.
  24. Goodwin P.J, Miller A, Del Giudice M.E et al. Elevated high - density lipoprotein chole - sterol and dietary fat intake in women with cyclic mastopathy. Am J Obstet Gynecol 1998; 179: 430.
  25. Ernster V.L, Goodson W.H 3rd, Hunt T.K et al. Vitamin E and benign breast "disease": a double - blind, randomized clinical trial. Surgery 1985; 97: 490.
  26. Blommers J, de Lange-De Klerk E.S, Kuik D.J et al. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double - blind, controlled trial. Am J Obstet Gynecol 2002; 187: 1389.
  27. Wilson M.C, Sellwood R.A. Therapeutic value of a supporting brassiere in mastodynia. Br Med J 1976; 2: 90.
  28. Hadi M.S. Sports Brassiere: Is It a Solution for Mastalgia? Breast J 2000; 6: 407.
  29. Mason B.R, Page K.A, Fallon K. An analysis of movement and discomfort of the female breast during exercise and the effects of breast support in three cases. J Sci Med Sport 1999; 2: 134.
  30. Colak T, Ipek T, Kanik A et al. Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment. J Am Coll Surg 2003; 196: 525.
  31. Diclofenac gel for osteoarthritis. Med Lett Drugs Ther 2008; 50: 31.
  32. A diclofenac patch (Flector) for pain. Med Lett Drugs Ther 2008; 50: 1.
  33. Dixon J.M. Hormone replacement therapy and the breast. BMJ 2001; 323: 1381.
  34. Graham C.A, Sherwin B.B. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive. J Psychosom Res 1992; 36: 257.
  35. Bancroft J, Rennie D. The impact of oral contraceptives on the experience of perimenstrual mood, clumsiness, food craving and other symptoms. J Psychosom Res 1993; 37: 195.
  36. Euhus D.M, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi - institutional cross - sectional study. J Am Coll Surg 1997; 184: 596.
  37. Uzan S, Denis C, Pomi V, Varin C. Double - blind trial of promegestone (R 5020) and lynestrenol in the treatment of benign breast disease. Eur J Obstet Gynecol Reprod Biol 1992; 43: 219.
  38. O'Brien P.M, Abukhalil I.E. Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase - only danazol. Am J Obstet Gynecol 1999; 180: 18.
  39. Gateley C.A, Miers M, Mansel R.E, Hughes L.E. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. J R Soc Med 1992; 85: 12.
  40. Srivastava A, Mansel R.E, Arvind N et al. Evidence - based management of Mastalgia: a meta - analysis of randomised trials. Breast 2007; 16: 503.
  41. Fentiman I.S, Caleffi M, Hamed H, Chaudary M.A. Dosage and duration of tamoxifen treatment for mastalgia: a controlled trial. Br J Surg 1988; 75: 845.
  42. Parlati E, Polinari U, Salvi G et al. Bromocriptine for treatment of benign breast disease. A double - blind clinical trial versus placebo. Acta Obstet Gynecol Scand 1987; 66: 483.
  43. Sismondi P, Biglia N, Giai M, Defabiani E. GnRH analogs in benign breast disease and breast cancer chemoprevention. A challenge for the year 2000. Eur J Gynaecol Oncol 1994; 15: 108.
  44. Wisbey J.R, Kumar S, Mansel R.E et al. Natural history of breast pain. Lancet 1983; 2: 672.
  45. Kumar S, Mansel R.E, Scanlon M.F et al. Altered responses of prolactin, luteinizing hormone and follicle stimulating hormone secretion to thyrotrophin releasing hormone/gonadotrophin releasing hormone stimulation in cyclical mastalgia. Br J Surg 1984; 71: 870.
  46. Gateley C.A, Mansel R.E. Management of the painful and nodular breast. Br Med Bull 1991; 47: 284.
  47. Duijm L.E, Guit G.L, Hendriks J.H et al. Value of breast imaging in women with painful breasts: observational follow up study. BMJ 1998; 317: 1492.
  48. Goodwin P.J, De Boer G, Clark R.M et al. Cyclical mastopathy and premenopausal breast cancer risk. Results of a case - control study. Breast Cancer Res Treat 1995; 33: 63.
  49. Plu-Bureau G, Thalabard J.C, Sitruk-Ware R et al. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case - control study among French women. Br J Cancer 1992; 65: 945.
  50. Aiello E.J, Buist D.S, White E et al. Rate of breast cancer diagnoses among postmenopausal women with self - reported breast symptoms. J Am Board Fam Pract 2004; 17: 408.

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies